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Abstract 
 
Advances in single cell analysis technologies are providing novel insights into 
phenotypic and functional heterogeneity within seemingly identical cell populations. 
RNA within single cells can be analysed by unbiased sequencing protocols or 
through more targeted approaches using in situ hybridisation. The Proximity Ligation 
AssaY for RNA (PLAYR) approach is a sensitive and high throughput technique that 
relies on in situ and proximal ligation to measure at least 27 specific RNAs by flow or 
mass cytometry. We provide detailed instructions on combining this technique with 
antibody-based detection of surface/internal protein allowing simultaneous highly 
multiplexed profiling of RNA and protein expression at single cell resolution. PLAYR 
overcomes limitations on multiplexing seen in previous branching DNA-based RNA 
detection techniques by integration of a transcript-specific oligonucleotide sequence 
within a rolling circle amplification. This unique transcript-associated sequence can 
then be detected by heavy metal (for mass cytometry) or fluorophore (for flow 
cytometry) conjugated complimentary detection oligonucleotides. Included in this 
protocol is methodology to label oligonucleotides with lanthamide metals for use in 
mass cytometry. When analysed by mass cytometry, up to 40 variables (with scope 
for future expansion) can be measured simultaneously. We used the described 
protocol to demonstrate intraclonal heterogeneity within primary cells from chronic 
lymphocytic leukaemia patients but it can be adapted to other primary cells or cell 
lines in suspension. This robust, reliable and reproducible protocol can be completed 
in 2-3 days and can be paused at several stages for convenience.  
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Introduction 
 
Analysis of single cells for their individual complexities in form and function allows 
greater understanding of biological systems. Through analysis and quantification of 
gene products at single cell resolution it is becoming evident that despite being 
genetically identical, there are significant differences in basal and perturbed gene 
expression even within populations of cells that would otherwise be considered a 
homogeneous “cell type”1.  This variance is thought to arise due to the stochastic 
nature of gene expression and differences in micro-environmental milieu of individual 
cells. Techniques for profiling and understanding of RNA expression at single cell 
resolution have rapidly progressed in recent years and the methods broadly fall into 
two complementary categories: single cell RNA-sequencing (scRNA-seq) or in situ 
hybridisation (ISH).  
Over the past 9 years, and since the publication of a landmark article 
describing an approach for single cell mRNA-seq2, different methodologies for 
scRNA-seq have evolved. All methods rely on 3 major steps: 1) Unique nucleotide 
barcoding and reverse transcription of RNA of each individual cell through either 
physical isolation3,4 or probabilistic labelling5; 2) amplification of the resulting cDNA; 
and 3) library preparation for sequencing. Recently this technology has been 
combined with oligonucleotide-labelled antibodies to allow simultaneous 
quantification of both protein and RNA within individual cells using DNA 
sequencing6,7. Despite being an extremely promising technology, a number of 
experimental constraints of scRNA-seq are pertinent: 1) Financial considerations 
may restrict sequencing depth resulting in a trade-off between the number of 
cells/samples that are analysed and the sensitivity for detection of transcripts with 
lower abundance, 2) the technique currently relies on reverse transcription using an 
oligo-dT primer and therefore analysis is limited to poly-adenylated RNA, 3) the 
method can be laborious and complicated and take weeks to months to produce 
informative data. Due to these limitations scRNA-seq may not always be practical for 
clinical applications.  
A complementary method to scRNA-seq is detection and quantitation of RNA 
at single cell resolution using ISH. This technique measures fewer RNAs that have to 
be preordained, but the transcripts can be sensitively quantified in a larger number of 
4 
 
cells, within a much shorter timeframe, and with less experimental complexity. Thus, 
quantification of the resulting signal by cytometry allows hundreds to thousands of 
cells to be analysed per second. The technology is an adaptation of fluorescent ISH 
(FISH), and relies on bright signals with high signal to noise ratio. Branching DNA 
technology also allows measurement of RNA in single cells using flow cytometry8, 
and specificity is increased through probe pairs that are required to bind in close 
proximity on their target RNA strand. Adjacently bound probes can then be detected 
using sequential binding of predesigned DNA molecules to form repetitive expanding 
structures of nucleotides that amplify the signal. However, there are currently only 4 
non-interfering versions of branching DNA sequences meaning opportunities for 
multiplexing using this method are limited. This restrictive feature of branching DNA 
is a significant limiting factor for utility in platforms such as mass cytometry that have 
higher multiplexing capabilities. An alternative methodology to branching DNA for 
increasing signal intensity is to use targeted padlock DNA probes and then produce 
concatenated copies of a resulting circular DNA molecule using rolling circle 
amplification catalysed by Phi29 DNA polymerase9. We have recently developed the 
Proximity Ligation AssaY for RNA (PLAYR), which provides routine simultaneous 
measurements for both RNA and proteins at single cell resolution with enhanced 
multiplexing capabilities for detection in both flow and mass cytometry platforms10. 
Here we provide a detailed protocol that allows analysis of protein expression 
using antibodies, and simultaneous detection of up to 27 RNA transcripts 
(multiplexing can be extended beyond this limit). We have now optimised the 
antibody staining procedure to allow robust and reproducible characterisation of 
surface and internal antigen expression while maintaining RNA integrity for the 
PLAYR assay. Although we describe the technique for the analysis of primary 
peripheral blood mononuclear cells (PBMCs) from chronic lymphocytic leukaemia 
(CLL) patients, it can be applied to other primary cells or cell lines that are in 
suspension. The protocol described here can potentially be adapted for the 
simultaneous measurement of RNA and protein in tissue sections using imaging 
technologies such as fluorescent microscopy and imaging mass cytometry. 
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Overview of the procedure  
PLAYR. A schematic overview of the critical steps to detect RNA in the PLAYR 
procedure and the method to combine this with antibody staining is depicted in 
Figure 1A. PLAYR specifically detects transcripts of interest by relying on proximal 
ligation of predesigned and specific PLAYR probe pairs (Figure 1B). Multiple probe 
pairs are designed to directly bind along each target RNA transcript to produce a 
robust signal with a high dynamic range of detection (1000 to fewer than 10 
transcripts per cell). Cells are fixed and permeabilised prior to incubation with 
PLAYR probe pairs that are designed to bind adjacently on their target transcripts 
(Steps 1-17). Two functional sections separated by a linker region of 10 adenine 
residues make up each probe. The 5’ end of the probe binds to its cognate target 
RNA sequence while the 3’ end forms one-half of a template for the binding and 
circularization of two additional oligonucleotides termed ‘insert’ and ‘backbone’. Only 
when both PLAYR probes bind to an RNA transcript in proximity can they generate 
the whole complementary platform for the formation of the nicked circular 
insert/backbone DNA molecule, which is ligated in a subsequent step (Steps 18-26) 
(Figure 1C). The circular insert/backbone DNA molecule is then amplified, via rolling 
circle amplification (RCA) using Phi29 DNA polymerase into its complementary 
concatenated form (Steps 27-28), thus yielding multiple copies of the cognate insert 
sequence that is detected by metal or fluorescently labelled detection 
oligonucleotides (Steps 29-32). Any off-target binding of single probes is insufficient 
to generate a complete circular DNA molecule that is required for RCA. Multiplexing 
is achieved through use of parallel and unique PLAYR systems (3’ probe sequences, 
insert oligonucleotide sequences, and the detection probe sequences) for each 
transcript (Figure 1). Unique insert sequences introduce a nucleotide barcode within 
the RCA that can be specifically detected for each transcript.  Common substrings 
between PLAYR insert sequences do not exceed 4bp in length but the latter have 
similar thermodynamic properties and base composition, allowing formation of 
unique RCA products with similar efficiencies. Our described insert sequences 
therefore allow simultaneous quantification of 27 different transcripts. A list of these 
27 PLAYR systems including PLAYR probe 3’ sequences, inserts, backbone and 
detection probe sequences are detailed in Table 1. 
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Combining antibody staining with PLAYR. Antibody staining has been optimised 
to alleviate effects on RNA copy numbers (through transcription and degradation) 
while preserving the surface and intracellular protein integrity for quantification. 
Staining using metal or fluorescently labelled antibodies that target intracellular 
antigens is performed alongside the incubation with PLAYR detection probes in the 
final stage of the assay (Steps 29-32). In contrast, surface antigens are stained in 
‘unfixed’ cells (Steps 5-7), covalently cross-linked to the cell using 
bis(sulfosuccinimidyl) suberate (BS3), and then fixed using paraformaldehyde (PFA) 
(Steps 8-10). If used first, PFA will compete with BS3 for protein amine groups 
reducing the efficiency of cross-linking. As unfixed cells are prone to changes in both 
transcript levels and protein post-translational modifications, the incubation with 
antibodies and subsequent BS3 and PFA treatments are performed on ice. We find 
that signal to noise ratios of the staining antibodies in unfixed cells on ice are similar 
if not better than those achieved using the standard mass cytometry staining protocol 
on fixed cells at room temperature (Figure 2). Once the cells are fixed they can then 
be permeabilised in methanol (Steps 11-12) and the PLAYR assay performed with 
minimal loss of antibody staining.  Cells can be stored for several months in 
methanol at -80oC (after step 12) without noticeable effects on RNA integrity or 
antibody binding.  
 
Limitations  
An inherent drawback of the technique is the paucity of unique heavy metal tags that 
can be used for detection of specific RNA targets and is currently limited to 40 
transcripts. This is due to the chemical properties of the polymer that is used to 
chelate the metal tags.  There are, however, efforts underway to expand the panel of 
unique tags to assay a larger spectrum of parameters11.  
A further limitation is the requirement for multiple probe pairs to detect a single 
transcript. Thus, it can be challenging to distinguish different isoforms, if the regions 
that are specific to each one are not big enough to accommodate multiple probes. In 
addition, due to constraints on the number of probe-pairs that are able to bind to 
transcripts of limited length, the detection of small RNAs such as miRNAs is 
problematic. In the case of miRNAs, the technique may be applicable for detection of 
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longer pre- or pri-miRNAs as surrogates. More generally, it may be possible to 
alleviate some of these limitations by using Locked Nucleic Acids (LNAs), which 
have stronger affinity for their targets12,13, and as such require less probe pairs to get 
a robust signal. However, the hybridization conditions for LNAs would have to be 
significantly modified to achieve good signal to noise ratios. 
Although the described PLAYR protocol should work well with most antibodies, there 
remains the possibility that the signal intensity of some antibodies may be 
compromised. To be certain, we recommend that the signal strength of each 
antibody to be tested with and without the PLAYR procedure. From a practical point 
of view, the protocol does involve many more wash steps than a standard antibody 
staining protocol, which could result in loss of cells available for final cytometric 
analysis.  
In addition, the issues that surround other single cell RNA technologies (such as 
specificity, sensitivity, and variable modes of expression) are likely also relevant with 
PLAYR14. Finally, unlike RNA-seq that uses next-generation sequencing, the 
technique is currently not applicable for discrimination of wildtype and mutated RNA 
transcripts. 
 
Experimental Design 
An overview of the experimental design workflow is illustrated in Figure 3.  
PLAYR Probe design. We recommend the use of 4 or 5 probe pairs for each 
transcript of interest to ensure a robust and specific signal. The signal generated 
from these probe pairs is dependent upon the RNA transcript copy number per cell, 
the efficiency of the probe binding sequences (some probes may fail to bind due to 
RNA secondary structures) and the duration of the RCA during the assay (see 
“Protocol optimisation” below). It is also possible to use different number of probe 
pairs, for different transcripts, according to their expected abundance. This does not 
constitute a problem for quantitative analysis, because quantification is only relative 
(as with any other affinity based reagent, e.g. antibodies). An example of how the 
number of probe pairs impacts PLAYR signal is illustrated in Supplemental figure 4a 
in the manuscript by Frei et al.10 . 
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PLAYR probes can be designed using our open-source R software package called 
PLAYRDesign9. Detailed instructions on how to download and install PLAYRDesign 
and its dependencies are available at https://github.com/nolanlab/PLAYRDesign. 
The PLAYRDesign software works by shortlisting candidate probes based upon their 
thermodynamic properties (using Primer3)15 and displaying them along the transcript 
in a graphical interface. Additional graphs are aligned to the target transcript to 
illustrate BLAST-evaluated sequence similarities with the rest of the transcriptome, 
as well as a database of repetitive sequences. Non-constitutively spliced exons are 
also displayed, thus aiding the user in manually choosing the best probe pairs. The 
user can then select the PLAYR system (i.e. the multiplexing sequences) desired for 
the 3’ end of the transcript probes and the complete probe sequences are generated 
in a .txt file.   
Handling of samples and reagents. All enzymes used during the PLAYR assay 
should be stored at -20oC and diluted in reaction buffer immediately before addition 
to the cells. T4 ligase buffer contains ATP and should therefore be batched to avoid 
degradation by freeze-thaw cycles. 
The procedure involves many more wash steps than a standard flow cytometry 
staining protocol, and as such cell loss is a concern. We recommend using 
Polypropylene V-bottom 200 µL PCR strips, or alternatively 1.5 mL Eppendorf tubes. 
Avoid regular U-bottom Polystyrene FACS tubes, as they will result in significant cell 
loss. Centrifugation of cells should preferably be performed in a swing bucket 
centrifuge and the supernatant ideally removed by aspiration (i.e. not by flicking the 
tubes). The use of small pipette tips during aspiration (e.g. P10) will give greater 
precision and help to minimise cell loss.  
When incubating cells make sure to use an agitation speed such that the cells will 
not deposit at the bottom during incubation (this is especially critical during 
amplification with phi29 polymerase). If using PCR strips, use a shaker with a very 
small orbit to guarantee mixing of the liquids. Tubes subjected to such vigorous 
agitation should always be spun down before opening to prevent cell loss, as the 
cells will be on the sides of the tube and on the cap. As cellular RNA can be prone to 
degradation by both internal and external RNAses, care must be taken to work as 
efficiently and quickly as possible, particularly when the cells are in any water-based 
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solution after fixation and before probe hybridisation (e.g. when the cells are remove 
from methanol prior to hybridisation). All samples should remain on ice during those 
critical steps to minimise RNAase activity. Once the circular DNA insert/backbone 
molecule is bound to the probe pairs and ligated, maintaining RNA integrity is less 
important (unless required for other relevant downstream applications). 
Controls. The specificity of the PLAYR signal can be verified using cell lines known 
to reliably express the RNA transcript of interest. Perturbation of target transcripts 
through cellular stimulation or using RNA knockdown/knockout followed by 
correlation of mean PLAYR signals with measurements obtained by qPCR can be 
used to further validate probe pair specificity (Figure 4A). Further guidance on 
examples of controls that may be useful can be found in the publication of Frei AP et 
al. (Supplementary figures 3 and 4). 
Each transcript of interest should be examined individually using all the designed 
probe pairs for the target RNA. The PLAYR probes for multiple transcripts are then 
pooled to ensure that the detection of each RNA is not compromised by multiplexing 
(Figure 4B). Reassuringly, we have never encountered cases of interference. 
Staining of proteins should be optimised for each antibody panel.  Antibodies should 
be stained according to the manufacturers’ recommendations (e.g. on fixed cells at 
room temperature for 30 mins) and compared with results obtained using the 
described PLAYR staining protocol. Verification of similar antibody staining patterns 
and clustering should be ensured using appropriate software, such as bivariant plots 
and viSNE analysis in Cytobank.  
We provide viability staining procedures for both mass and flow cytometry in this 
protocol. We advise the inclusion of this procedure as cell viability can greatly affect 
RNA levels detected within cells. For example, see Figure 1B cisplatin-194Pt vs 
ACTB mRNA; dead cells (highest cisplatin levels) are associated with much lower 
ACTB mRNA. 
Further useful controls and troubleshooting steps are listed in Table 2. 
Protocol optimisation. The duration of the RCA can be altered to optimise signal 
intensity.  We have found that 4hrs for mass cytometry and 2hrs for flow cytometry 
yield comparable and strong signal amplifications.  Longer incubation times (16 hrs) 
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further enhance signal levels but may be detrimental to antibody staining and final 
cell numbers, and will somewhat increase background as well. In our experience 
cells that do not generate a detectable signal after 2-4hrs tend not to show enhanced 
signal even after longer RCA times. 
The PLAYR protocol may be optimised further to help preserve efficient antibody 
binding and, for flow cytometry, fluorophore stability. We have found that the 
methanol permeabilisation step may be excluded as the Tween20 present within the 
probe hybridisation buffer is sufficient to permeabilise the cells for RNA detection 
(Supplementary Figure 1).  However, exclusion of the methanol step from the 
protocol means that the cells can no longer be stored at -80oC for a prolonged period 
of time and, as Tween20 does not permeabilise the nuclear membrane, RNA 
residing within this compartment may not be stained during the assay. Lowering of 
the temperature during PLAYR probe hybridisation and post-hybridisation wash 
steps (17 and 22) from 40oC to 37oC may help further maintain antibody staining. 
Also, the dilution of the detergent Tween20 used during the probe hybridisation step, 
and the concentration of SSC during the PLAYR post-hybridisation wash can be 
modified if needed. Despite the fact that we see no major differences in RNA 
detection for our transcripts of interest during less stringent conditions 
(Supplementary Figure 2), we advise that all changes in protocol need to be 
controlled appropriately for your gene(s) of interest (see “Controls” above).  
Considerations specific for use with mass cytometry. Detection probes can be 
purchased as 5’ C6-thiol modified oligonucleotides that can then be labelled using 
commercial Maxpar X8 metal labelling kits (Fluidigm). A detailed protocol for 
labelling detection probes is described in BOX1. Metal-labelled detection probes can 
be validated by diluting the oligonucleotides in water (e.g. 100pM – 1nM) and 
running the samples through the mass cytometer to confirm presence of the metal 
ion. Validation that each PLAYR system (including detection probe) is working with 
equal efficiently can also be performed using a suspension cell line of your choice to 
probe a gene of known high abundance. An example using 2-3 probe pairs that 
target GAPDH transcripts in the B-cell line MAVER1 is shown (Figure 4C).  
We include in this protocol an optional step for mass cytometry which enables 
Palladium (Pd)-based barcoding of up to 20 samples so they can be subsequently 
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pooled together and analysed as one sample 16. The use of Pd barcoding has been 
optimised to ensure that it does not interfere with the PLAYR assay and should be 
performed after probe hybridisation (steps 20-22) as described. Pd barcoding is 
encouraged as it has multiple benefits including: significantly reducing cell loss 
during processing, allowing the use of fewer starting number of cells per sample; 
removing variability in PLAYR and internal antibody staining efficiencies; decreasing 
reagent use; decreasing instrument measurement time; and reducing sample 
processing time. In silico separation of the samples is performed after data collection 
using an integrated feature on the CyTOF system control software. Further details 
are can be found in the Cell-ID 20-Plex Pd Barcoding Kit user guide on the Fluidigm 
website. 
Considerations for use with flow cytometry. Care must be taken regarding the 
choice of fluorophores for surface antigen staining. Alongside the usual concerns 
regarding spectral overlap, additional attention must be paid to whether fluorophores 
conjugated to surface staining antibodies will be inactivated during the PLAYR 
staining procedure. Fluorophores need to withstand chemical treatments (e.g. BS3 
crosslinking, PFA treatment and methanol), temperatures, and buffers used during 
the PLAYR assay. Generally, smaller fluorophores are more resistant to these 
conditions than protein-based fluorophores which can be denatured by methanol17. A 
list of 10 fluorophores that we have tested for performance under different PLAYR 
optimisation conditions can be found in Supplementary Table 2.  However, 
inactivation is less of a concern for fluorophores that are employed at the end of the 
protocol (i.e. for PLAYR detection probes and internal antigen staining). The use of 
PLAYR with advanced multi-parameter flow cytometry may be limited by the number 
of channels and suitable fluorophores. Please see the section on “Protocol 
Optimisation” above for other potential ways to increase surface antibody staining 
efficiency and preservation of fluorophores. As with routine flow cytometry, a 
negative control sample for PLAYR (e.g. assay performed with probe 1 or 2 only – 
see Figure 5A) is required to correct for background fluorescence. Finally, all 
incubation steps when using fluorophores should be performed in the dark. 
 
MATERIALS 
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BIOLOGICAL MATERIALS  
• Cultured cell lines of interest. We demonstrate our protocol in this manuscript 
using the B-cell cell lines MEC1 (DSMZ, cat. no. ACC 497), MAVER1 (ATCC, 
cat. no. CRL-3008) and the T-cell line HUT78 (ATCC, cat.no. TIB-161) that 
were authenticated by STR analysis and tested negative for mycoplasma. 
! CAUTION: Regularly check cell lines to ensure they are authentic and are not 
infected with mycoplasma. 
 
• Primary cells of interest. We have also demonstrated the protocol use on 
primary CLL PBMC samples from consenting patients. 
! CAUTION All experiments involving animal or human samples should adhere to the 
relevant governmental and institutional ethics guidelines and regulations. CLL cells 
used for this Protocol were obtained from the peripheral blood taken from patients 
with informed consent and with the approval of the Liverpool Research Ethics 
Committees.  
! CRITICAL Cryo-preserved CLL samples stored in the Liverpool Leukemia Biobank 
were prepared using standard protocols and stained immediately after thawing. 
 
REAGENTS 
(Optional) Surface and internal antibody staining 
! CRITICAL Staining with antibody is not required for RNA to be detected by the 
PLAYR assay.  Surface and/or intracellular antibodies should be included if analysis 
of RNA expression is performed in specific cell types or cell phenotypes within mix 
populations of cells (e.g. studying B cells within PBMC). 
• Metal- (For mass cytometry; Fluidigm)11 or fluorophore-conjugated (for flow 
cytometry) antibodies. 
! CRITICAL Fluorophore-conjugated antibodies used to stain surface antigen need 
to withstand conditions used during the remaining steps of the protocol (i.e. PFA 
fixation, MeOH treatment and PLAYR incubations). See the section “Considerations 
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for use with flow cytometry” for more details. For a list of antibodies used in this 
Protocol, see Supplementary Table 1. 
• Bis(sulfosuccinimidyl) suberate (BS3 crosslinker; Sigma-Aldrich, cat. no. 
S5799)  
• Cell staining buffer (Fluidigm, cat. no. 201068) 
• Phosphate-buffered saline (PBS; Gibco, cat. no. 10010015) 
 
PLAYR 
• 100µM PLAYR probes (Integrated DNA technologies). PLAYR probes can be 
designed using our open-source R software package called PLAYRDesign9. 
Detailed instructions on how to download and install PLAYRDesign and its 
dependencies are available at https://github.com/nolanlab/PLAYRDesign (see 
Experimental Design “PLAYR Probe design”). See Table 1 for Oligonucleotide 
sequences for 27 PLAYR systems. 
• 100µM 5’-phosphorylated insert and backbone oligonucleotides (Integrated 
DNA technologies) 
• RNAsin Plus (Promega, cat. no. N2611/N2615) 
! CRITICAL - Other RNAsins may result in suboptimal inhibition and compromise 
RNA detection. 
• 25% (vol/vol) Poly Vinyl Sulfonic acid (PVS) (Polysciences, cat. no. 9002-97-
5) 
• 200mM Ribo-nucleoside vanadyl complex (RVC) (New England BioLabs, cat. 
no. S1402S) 
! CRITICAL - RVC precipitates at low temperatures and oxidises upon repeat freeze 
thawing. Thaw the bottle of RVC, heat it up to 65oC and produce an even 
suspension of RVC precipitates by gentle agitation before aliquoting. 100uL aliquots 
can then be produced which should be stored at -20oC. Similarly, when using an 
aliquot, heat it up to 65oC with agitation to dissolve any precipitate that has re-formed 
upon cooling. 
• UltraPure™ Salmon Sperm DNA Solution (Life Technologies, cat. no. 
15632011) 
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• 16% (wt/vol) Paraformaldehyde (Electron Microscopy Sciences, cat. no. 
15710) 
! CAUTION – Skin contact should be avoided. Wear appropriate Personal Protective 
Equipment (PPE). 
! CRITICAL - Keep the ampoule at 4oC in the dark once opened and discard after 
one week. 
• Methanol (Fisher Scientific, cat. no. M/4056/15) 
! CAUTION – Methanol is toxic. Wear appropriate PPE. 
• T4 DNA Ligase (Thermo Scientific, cat. no. EL0011) 
• Phi29 DNA polymerase (Thermo Scientific, cat. no. EP0091) 
• 10mM dNTPs (Invitrogen, cat. no. 18427013) 
• Cell staining buffer (Fluidigm, cat. no. 201068) 
• Tween20 (Thermo Scientific, cat. no. BP337-100) 
• 10X PBS pH 7.4 (Invitrogen, cat. no. AM9625) 
• 20X Saline-Sodium Citrate solution (20X SSC; Fisher Scientific, cat. no. 
10418353) 
 
Additional reagents for mass cytometry 
• 1µM Thiol-Modified C6 S-S detection probe(s) for detection by mass 
cytometry (see BOX1 for protocol for metal labelling of detection probes; 
Integrated DNA technologies). See Table 1 for Oligonucleotide sequences for 
27 PLAYR systems. 
• MaxPar® Metal Labeling Kit(s) (Fluidigm) 
• Cell-ID Intercalator-Ir (Fluidigm, cat. no. 201192A) 
• (Optional) Cell-ID Cisplatin (Fluidigm, cat. no. 201064) 
! CRITICAL Use cisplatin if identification of cell viability is required. 
• (Optional) Cell-ID 20-Plex Pd Barcoding Kit (Fluidigm, cat. no. 201060) 
! CRITICAL Pd barcoding allows samples to be pooled together into one tube and 
provides a number of benefits.  See the description of Pd barcoding within the 
Experimental design section for more details. 
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• Maxpar water (Fluidigm, cat. no. 201069) 
• EQ Four Element Calibration Beads (Fluidigm, cat. no. 201078) 
 
Additional reagents for flow cytometry 
• 1µM Fluorophore-conjugated detection probe(s) (resuspended in ddH2O) for 
detection by flow cytometry (Integrated DNA technologies). See Table 1 for 
Oligonucleotide sequences for 27 PLAYR systems. 
• (Optional) Live/Dead® Fixable Dead Cell Stain Kits (Invitrogen) 
!CRITICAL Use Live/Dead® Fixable Dead Cell Stain Kits if identification of cell 
viability is required. 
 
 
EQUIPMENT 
General equipment 
• Filter tips 
• Polypropylene V-bottom 200 uL PCR strips (Fisher Scientific cat. no. 
11849241), or alternatively 1.5 mL Eppendorf tubes (STARLABS, cat. no. 
S1615-5500) 
• Refrigerated microcentrifuge 
• Mass cytometer or flow cytometer; we use the Helios (Fluidigm) and Attune 
NxT (Invitrogen) respectively. 
  
Antibody staining  
• Weighing scale capable of 4 decimal places or more for the weighing of BS3 
(Fisherbrand™ Analytical Balance, cat. no. 15315113). Alternatively, pre-
weighed BS3 may be purchased (Thermo Scientific, cat. no. 21585). 
 
PLAYR 
• Thermomixer (Eppendorf ThermoMixer® C, cat. no. 5382000031) 
 
Software 
16 
 
• Fluidigm CyTOF system control software for mass cytometry 
(www.fluidigm.com/software) 
• NxT software (Thermofisher; cat. no. A25554) for the Attune flow cytometer 
(or equivalent) 
• Software appropriate for analysis of multiparametric mass cytometry data files 
(e.g. Cytobank (https://www.cytobank.org/), Cytosplore 
(https://www.cytosplore.org/), etc.) 
• R software (https://www.r-project.org/) for PLAYR probe design 
• PLAYRDesign software to design PLAYR probes for the RNA of interest is 
available at https://github.com/nolanlab/PLAYRDesign  
 
 
REAGENT SETUP 
10% (vol/vol) Tween20. Dissolve one part Tween20 to nine parts DEPC-treated 
ddH2O. Store at room temperature (RT: 15-30°C) for up to 6 months. 
PLAYR oligonucleotides. PLAYR probes, inserts, and backbone oligonucleotides 
are delivered dry with purification by standard desalting. Resuspend the 
oligonucleotides in DEPC-treated ddH2O at a concentration of 100µM, and store 
them at -20oC for up to 3 years. To increase the speed of the protocol, it is 
recommended that all oligonucleotides are aliquoted before storing at -20oC. PLAYR 
probes with the same insert system that target an individual RNA transcript can be 
mixed together in equal quantities prior to aliquoting and freezing at -20oC. For 
example, if 4 probe pairs target a unique transcript, then these 8 probes may be 
mixed together in equal quantities and stored as 8uL aliquots. Each aliquot is 
enough to make 1mL of hybridization buffer and each aliquot can then be pooled 
together prior to heating (see PLAYR probe hybridization buffer below). 
PLAYR dilution buffer (PBST). Take a 9mL aliquot of DEPC-treated ddH2O and 
add 1mL of DEPC-treated 10X PBS. Add 100uL of 10% (vol/vol) Tween20 and place 
on ice. Prepare this buffer fresh at the start of PLAYR assay (step13). 
PLAYR wash buffer (PBSTR). Add RNAsin Plus to PBST at a final concentration of 
4U/mL. Prepare this buffer fresh at the start of PLAYR assay (step13). 
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PLAYR wash buffer with extra RNAsin (PBSTR+). Add RNAsin Plus to PBST to a 
final concentration of 40U/mL. Prepare this buffer fresh at the start of PLAYR assay 
(step13). 
PLAYR Probe hybridization buffer. To simplify and speed up the procedure for 
preparation of this buffer we recommend aliquoting PLAYR probes, so that each 
aliquot is enough for 1mL of hybridization buffer (see reagent setup of “PLAYR 
oligonucleotides” above). We make this buffer at a minimum volume of 1mL, which 
therefore uses 1 aliquot of each transcript probe set, and 1 aliquot of RVC (enough 
for 10 samples or less).  If more than 10 samples are being stained, then 2mL would 
be made from 2 aliquots of PLAYR probes and RVC etc. Prepare this buffer fresh at 
the start of PLAYR assay (step14) using the following procedure: 
1. Thaw and pool together the required PLAYR probes and leave at room 
temperature. For 1mL of hybridization buffer initially heat an aliquot of RVC 
using a Thermomixer to 65oC with vigorous agitation (we use 1400rpm) for 
25minutes to dissolve any precipitation (2 aliquots are required for 2mL, etc).  
2. While the RVC is incubating at 65oC, mix together the following at room 
temperature for 1mL of hybridization buffer:  
Reagent     Volume Final concentration 
DEPC-treated ddH2O   XµL  - 
DEPC-treated 20X SSC   50µL  1X 
10% (vol/vol) Tween20   100µL   1% (vol/vol) 
25% (vol/vol) PVS     100µL   2.5% (vol/vol) 
Salmon Sperm DNA    10µL   100ug/mL 
The volume XµL of DEPC-treated ddH2O is calculated as the remaining 
volume required to produce 1 mL of solution after addition of all other 
reagents, including RVC, RNAsin, and probes (see Step 5 below). 
3. Remove the RVC from the Thermomixer and leave at room temperature to 
cool while preparing the cells (Step 15 of the main procedure). 
! CRITICAL – Do not cool the RVC on ice as this will cause it to precipitate. 
4. 10 minutes before addition of the PLAYR hybridization buffer to the cells heat 
the probe mixture for 5 mins at 90oC and then immediately place on ice for 5 
mins to avoid denaturing the RNAsin.  
5. Immediately before addition of the PLAYR hybridization buffer to the cells, 
add the following to complete its constituents: 
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Reagent    Volume   Final concentration 
200mM pre-heated RVC   100µL   20mM 
RNAsin Plus    1µL     40U/mL 
Pre-heated PLAYR probes  1µL of each   100nM of each 
 
PLAYR Post hybridization wash Dilute DEPC-treated 20X SSC to 4X SSC (1:5 
(vol:vol) dilution) in PBST and add RNAsin Plus to a final concentration of 40U/mL. 
Prepare fresh just before use (step21). 
PLAYR backbone/insert hybridization mix. Using PBST as the diluent, prepare a 
solution containing 1X DEPC-treated SSC, 40U/mL RNAsin Plus, 100nM backbone 
oligonucleotide and 100nM of each insert oligonucleotide. Prepare fresh just before 
use (step23). 
PLAYR Ligation mix. Using DEPC-treated ddH2O as the diluent, prepare a solution 
containing 1X T4 Ligase Buffer (as supplied by manufacturer), 5U/mL T4 Ligase and 
40U/mL RNAsin. Prepare fresh just before use (step25). 
PLAYR Phi29 amplification mix. Using DEPC-treated ddH2O as diluent, prepare a 
solution containing 1X Phi29 Buffer (as supplied by manufacturer), 5U/mL Phi29 
DNA polymerase and 200µM dNTP. Prepare fresh just before use (step27). 
PLAYR Mass Cytometry Detection probe buffer. Use this buffer when performing 
mass cytometry. Using cell staining buffer as a diluent, prepare a solution containing 
1nM of each metal-conjugated detection probe and, if required, appropriate 
concentration of metal-labelled antibodies against internal antigens. Prepare fresh 
just before use (step29). 
PLAYR Flow Cytometry Detection probe buffer. Use this buffer when performing 
flow cytometry. Using PBST as a diluent, prepare a solution containing 1nM of each 
fluorophore-conjugated detection probe and, if required, appropriate concentration of 
fluorophore-labelled antibodies directed against internal antigens. Prepare fresh just 
before use (step29). For a list of antibodies used in this Protocol, see Supplementary 
Table 1. 
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Cell-ID Intercalator-Ir buffer. Make a 1:5 dilution of 8% (vol:vol) PFA with PBS to 
generate a 1.6% (vol:vol) solution and add Cell-ID Intercalator-Ir to a final 
concentration of 62.5nM (i.e. 1:8000 (vol:vol) of 500µM). Intercalator-Ir buffer should 
be kept at 4oC in the dark and can be stored for up to 1 week. 
 
 
 
 
 
 
 
 
PROCEDURE 
 
! CRITICAL See Fig. 1C for an overview of the workflow.  
Cell preparation. Timing: 6mins 
1. Count the cells and place 3x106 cells into an Eppendorf on ice. In the example 
described in this Protocol, we use PBMC cells, but the approach can be used 
with other primary or cultured cell lines of interest. 
! CRITICAL STEP We encourage a minimum of 3x106 cells per sample, due to cell 
loss throughout the assay. This gives approximately (depending on pipetting 
efficiency) 1.5x106 cells at the final wash step to analyze by mass/flow cytometer. 
Fewer cells per sample may be used for mass cytometry if the experimental plan 
includes Pd barcoding and pooling of the samples (performed during step 20-22) 
(see Experimental Design, “Considerations specific for use with mass cytometry”).  
 
(Optional) Staining to identify dead cells. Timing: 15mins 
! CRITICAL Use viability staining if identification of cell death is required. See 
Experimental design – “General considerations” section for more details. 
! CRITICAL If staining to identify dead cells is not required proceed to Surface 
Antibody Staining. 
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2. Pellet the cells by centrifugation (500xg/3min/4oC) and remove the 
supernatant. Wash the cells once by adding 200µL room temperature PBS, 
followed by centrifugation and removal of the supernatant. 
3. Resuspend cells in either 200µL of a 1:1000 (vol:vol) dilution of Cell-ID 
Cisplatin (for mass cytometry) or LIVE/DEAD viability dye (for flow cytometry) 
in room temperature PBS and incubate for 5min (cisplatin) or 10min 
(LIVE/DEAD dye) at room temperature.  
! CRITICAL STEP Incubation of cells with viability dye should be done at RT, since 
cold conditions cause non-specific staining of live cells. 
 
Surface Antibody Staining. Timing: 1hr 15mins 
! CRITICAL Surface antibody staining may be omitted and this will not compromise 
the PLAYR assay. If surface antibody staining is not required, only perform the PBS 
cell wash in step 7 and proceed to step 10. 
4. Wash cells (500xg/3min/4oC) once in 200µL ice cold cell staining buffer. 
5. Resuspend cells in ice cold antibody cocktail (for a list of antibodies used in 
this Protocol, see Supplementary Table 1) in cell staining buffer 
(100µL/3x106cells). Leave on ice for 30mins, agitating the cells every 10mins. 
! CRITICAL STEP Cells must remain on ice at all times to avoid further 
transcription and RNA changes in live cells that may result from binding of 
surface antibodies. 
6. Wash cells (500xg/3min/4oC) in 200µL ice cold cell staining buffer. 
7. Wash cells (500xg/3min/4oC) in 200µL ice cold PBS. 
8. Resuspend cells in 50µL of 5mM BS3 crosslinker in ice cold PBS – mix 
immediately and leave on ice for 30mins, agitating the cells every 10mins. 
! CRITICAL STEP The NHS-ester moiety within BS3 readily hydrolyses upon 
contact with water. Warm the vial to room temperature to avoid moisture 
formation upon opening and weigh fresh powder for each experiment/timepoint. 
Dissolve the powder immediately before addition to the cells to avoid loss of 
reactivity 
9. Pellet cells (500xg/3min/4oC) and remove supernatant. 
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Cell Fixation and permeabilisation. Timing: 25mins 
10. Resuspend cells in ice cold 1.6% (wt/vol) PFA at a maximum cell 
concentration of 2x106 cells/mL. Leave on ice for 10 minutes. 
! CRITICAL STEP – PFA fixation should be performed at room temperature if no 
surface antibody staining and BS3 cross-linking was performed. 
11. Spin-down the cells (500xg/3min/4oC), remove the supernatant, loosen the 
pellet by flicking the tube and add ice-cold methanol dropwise, while vortexing 
(300uL/3x106cells) 
! CRITICAL STEP - Methanol can cause clumping of cells if they are not in a 
single cell suspension 
12. Incubate for 10 minutes on ice. 
! CRITICAL STEP - Cells in methanol should always be kept on ice during 
handling. 
! PAUSE POINT - Once placed in methanol the cells can be stored at -80oC for 
an extended period of time (several months) without RNA degradation.  
 
PLAYR and intracellular antibody staining. Timing 7-8hrs for flow cytometry or 9-
10hrs for mass cytometry with frequent incubations steps 
13. Prepare PBST, PBSTR and PBSTR+ buffers (see Reagent Setup) and place 
on ice. 
14. Prepare PLAYR probe hybridization buffer (refer to Reagent Setup for a 
detailed guide). 
15. Spin-down the cells (800xg/3min/4oC) which are suspended in methanol and 
wash (800xg/3min/4oC) with 200µL ice cold PBSTR+ buffer. 
! CRITICAL STEP Methanol has a higher density at -80oC and pelleting of cells 
by centrifugation may be inhibited; warm the tube on ice for 5mins if stored at -
80oC before centrifugation. 
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! CRITICAL STEP Once cells are removed from ice-cold methanol, RNA 
degradation can set in and hence speed in sample preparation during this stage 
is essential to maintain RNA integrity and PLAYR signal. 
16. Resuspend cells immediately in 100µL room temperature PLAYR probe 
hybridization buffer and place on the Thermomixer at 40oC. 
! CRITICAL STEP Due to the small volumes used, the failure to remove all 
PBSTR + wash supernatant before addition of probe hybridization buffer can 
affect assay efficiency. 
17. Incubate cells for a 1hr (this can be extended if signal is weak) at 40oC with 
vigorous agitation (we use 1400rpm). 
18. (Optional) When analysing using mass cytometry, remove an aliquot of PBST 
from the ice while incubating the cells, and place at room temperature to 
perform cell Pd barcoding (step 20). 
! CRITICAL STEP Only perform this step if you are Pd barcoding for mass 
cytometry. 
19. Wash cells once (800xg/3min/4oC) with ice cold PBSTR. 
20. (Optional) When analysing using mass cytometry, perform Pd barcoding at 
room temperature in PBSTR+ buffer (add RNAsin Plus to room temperature 
PBST from step 16). We recommend resuspending the cells with 99µL of 
room temperature PBSTR+ and then adding 1µL of the appropriate Pd 
barcode and incubate for 10mins. 
! CRITICAL STEP Only perform this step if you are using Pd barcoding for mass 
cytometry. Pd barcoding allows samples to be pooled together into one tube 
which provides a number of benefits.  See Experimental design – General 
considerations for more details. 
21. Wash cells twice (800xg/3min/4oC) in 200µL ice cold PBSTR and prepare 
PLAYR post hybridization wash buffer (see Reagent Setup) and place on ice. 
22. Resuspend cells in 100µL ice cold post probe hybridization buffer and 
incubate for 20mins at 40oC with vigorous agitation (we use 1400rpm).  Pd-
barcoded cells for mass cytometry may be pooled together at this stage ! 
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CRITICAL STEP Remember to increase the volume of buffer if using 
increased number of cells per sample. 
23. Wash cells twice (800xg/3min/4oC) in 200µL ice cold PBSTR and prepare 
PLAYR backbone/insert hybridization mix (see Reagent Setup) on ice. 
24. Resuspend cells in 100µL ice cold PLAYR backbone/insert hybridization mix 
and incubate at 37oC for 30mins under agitation (we use 1100rpm). 
25. Wash cells twice (800xg/3min/4oC) in 200µL ice cold PBSTR and prepare 
PLAYR Ligation mix (see Reagent Setup) on ice. 
26. Resuspend cells in 50µL of ice cold PLAYR Ligation mix and incubate at 21oC 
for 30mins with agitation (we use 1100rpm). 
27. Wash cells twice (800xg/3min/4oC) in 200µL ice cold PBSTR and prepare 
PLAYR Phi29 amplification mix (see Reagent Setup) on ice. 
28. Resuspend cells in ice cold PLAYR Phi29 amplification mix and incubate at 
30oC with agitation for ≥ 2hrs (flow cytometry) or ≥ 4hrs (mass cytometry). 
Longer incubations (up to overnight) may increase signal intensity. We 
typically agitate the cells at 1100rpm. In any case, make sure that you use a 
speed such that the cells do not settle at the bottom of the tubes, as this will 
decrease the amplification efficiency).  
29. Wash cells twice (800xg/3min/4oC) in 200µL ice cold cell staining buffer (mass 
cytometry) or ice cold PBSTR (flow cytometry), and prepare PLAYR mass 
cytometry detection probe buffer or PLAYR flow cytometry detection probe 
buffer on ice. Intracellular antibodies can also be added to this buffer as 
described in the Reagent Setup section. 
30. Resuspend cells in 100µL of the appropriate ice cold detection probe buffer 
and incubate at 37oC for 30mins with agitation (we use 1100rpm). 
31. Wash cells twice (800xg/3min/4oC) in ice cold cell staining buffer (for mass 
cytometry) or twice in ice cold PBSTR (for flow cytometry). 
! CRITICAL STEP Do not use PBSTR to wash cells for mass cytometry after 
detection probe hybridisation as it will lead to signal loss. 
32. For flow cytometry, resuspend cells in ice cold PBS and analyse immediately 
using laboratory specific protocols. For mass cytometry, resuspend cells in 
Cell-ID Intercalator-Ir buffer, incubate for 1hr at room temperature or for up to 
2 weeks at 4oC and proceed to Step 33. 
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? TROUBLESHOOTING 
! PAUSE POINT Samples for mass cytometry can be stored at 4oC for up to two 
weeks in Cell-ID Intercalator-Ir buffer with minimal loss of signal. 
 
(Optional) Preparation of samples for mass cytometry analysis. Timing 20mins 
CRITICAL Steps 33-37 describe how to prepare the samples for mass cytometry.  
33. To prepare the sample for the mass cytometer, wash the cells once 
(800xg/3min/4oC) with 1mL cell staining buffer then once (800xg/3min/4oC) 
with 1mL Maxpar water. 
34. Resuspend cells in 1mL Maxpar water, filter cells through a 30µM filter and 
count cells. 
35. Adjust the concentration of cells to a maximum of 5x105cells/mL in Maxpar 
water. 
36. Add EQ Four Element Calibration Beads 1:10 (vol:vol), mix by vortexing and 
then analyse using the mass cytometer. Details on instrument and panel-
template setup can be found at www.fluidigm.com/productsupport/cytof-
helios-support-hub 
37. Analyse data using linked software (e.g. cytobank). 
? TROUBLESHOOTING 
 
TIMING 
Step 1, Cell preparation: 6mins 
(Optional) Steps 2-4, Staining to identify dead cells: 25mins 
Steps 5-9, Surface antibody staining: 1hr 15mins 
Step 10-12, Cell fixation and permeabilization: 25mins 
Steps 13-32, PLAYR and internal antibody staining: 7-8hrs for flow cytometry or 9-
10hrs for mass cytometry 
(Optional) Steps 33-36, Preparation of samples for mass cytometry: 20mins 
Step 37, Analysis of mass cytometry data: 2-6 hours 
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BOX1 – Metal labelling of detection probe oligonucleotides: 7hrs with an overnight 
incubation step 
 
TROUBLESHOOTING 
Troubleshooting advice can be found in Table 2 
 
ANTICIPATED RESULTS 
This protocol provides a detailed and step-by-step guide to multiplexed and 
simultaneous detection of RNA and antigen expression using the PLAYR technique 
combined with antibody labelling for up to 40 variables. The methodology described 
allows the use of the technique for either flow or mass cytometric applications.  
 
Assay optimisation. We recommend optimising PLAYR and antibody assays 
separately before the two procedures are combined (Figure 3). We have optimised 
the PLAYR assay by studying control genes with high copy numbers in a cell line to 
confirm assay efficiency. See Figure 5A for an example comparing signal intensity 
achieved in primary CLL cells vs. the cell line MEC1. It is important to appreciate that 
expression of “classical” control genes may not be uniform within cell populations, 
particularly in primary cells. For example, we observed high unimodal expression of 
ACTB, RPL27 and GAPDH in cell lines, but GAPDH exhibited a multimodal pattern 
of expression in primary CLL cells (Figure 5A top right panel). Upon confirming that 
each PLAYR detection probe was correctly labelled and working with similar 
efficiencies on our positive control gene (Figure 4C), we applied the assay to other 
transcripts of interest. To confirm that PLAYR signals were specific for each 
transcript, we performed a time course analysis of RNA expression changes, known 
to occur on in vitro PMA and Ionomycin stimulation of MAVER1 cells and correlated 
PLAYR mean signal intensities with qPCR quantification (Figure 4A and Suppl. Fig 
2). When optimised the pattern of expression of each individual transcript examined 
on its own or when multiplexed should be consistent (Figure 4B).  
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In the top two row of panels in Figure 2, we plot CD4 expression (y-axis) vs CD335, 
CD161, CD45, CD14, CD278, CD3, CD194, and CD5 (x-axes)). As demonstrated, 
detection of antigens (cell identity) should not be compromised by additional steps 
required for the PLAYR assay (second row of panels in Figure 2) when compared 
with standard antibody staining of cells (top row panels). Similarly, the additional 
steps for antibody staining of cells should not affect the performance of the PLAYR 
assay. 
 
Insights into genotypic and phenotypic heterogeneity at single cell resolution. 
The main advantage of the combined analysis of antigen and RNA expression using 
the technique is the potential to address genotypic and phenotypic variations at 
single cell resolution. Our study of primary CLL cells (Figure 5) is an example of how 
the technique can provide novel insights into intraclonal heterogeneity. CLL cells 
from a single patient were resolved into newly emerged vs old quiescent cells 
(Figures 5D) based on the intensity of CXCR4 and CD5 surface antigen 
expression18. It is clear that there is considerable variation of Ki67 expression 
(Figure 5E) and CD83, JUND and TXNIP mRNAs as measured by PLAYR (Figure 
5F). This was not apparent in previously reported studies performed on whole cell 
populations17,19-21. Additional computational analyses allow clustering of seemingly 
identical neoplastic CLL cells into distinct phenotypic and genotypic subpopulations 
(Figures 5G and H) with a potential for variant behaviour and therapeutic 
responses. Hence, the combined and multiplexed analysis of antigen and RNA is a 
useful tool to monitor and track CLL disease evolution, biology, and heterogeneity. 
Relevant questions regarding heterogeneity in other cellular contexts can be 
addressed using our protocol. 
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BOX1 – Metal labelling of detection probe oligonucleotides 
Reagents 
• Ice cold 100% Ethanol 
• Ice cold 75% Ethanol 
• 3M Sodium Acetate, pH 5.2 (Thermo Scientific, cat. no. R1181) 
• Bond-Breaker™ TCEP Solution, Neutral pH ((Thermo Scientific, cat. no. 
77720) 
• Maxpar® X8 Antibody labelling Kit (Fluidigm) 
! CRITICAL The choice of metal for each PLAYR detection probe depends upon 
your panel design and PLAYR insert system used. 
• Detection probe carrying a 5’-Thiol-Modifier C6 S-S (IDT) 
Equipment 
• Nanodrop spectrophotometer (Thermo Scientific, cat. no. ND-2000) 
• Centrifugal filter with 30kDa MWCO (EMD Millipore, Cat. No. UFC503024) 
• Centrifugal filter with 3kDa MWCO (EMD Millipore, Cat. No. UFC500396) 
 
Procedure. Timing: 7hrs with an overnight incubation step  
1. Resuspend the detection probes carrying a 5’-Thiol-Modifier C6 S-S at 250µM 
in ddH2O. Calculate or make a note of the starting number of nmoles for each 
detection probe as this will be required during calculations in step 15. 
2. Add TCEP to a final concentration of 50mM and incubate at room temperature 
for 30mins. 
3. Increase the volume if required to a minimum of 200µL using ddH2O and add 
0.1 volumes 3M Sodium acetate and 3 volumes pure ethanol. Vortex to mix. 
Precipitate detection probe at -20oC overnight. 
! PAUSE POINT – Alternatively, PLAYR DNA detection probes can be stored 
at -80oC in 75% ethanol for up to 6 months without degradation before being 
processed. 
4. From the metal labelling kit, spin polymer tube (4000xg/30sec/RT) to ensure 
all reagent is at the bottom. 
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5. Resuspend polymer in 95µL L-Buffer and then add 5µL of lanthamide metal 
solution, mix by pipetting. 
6. Incubate polymer-metal mix at 37oC for 30mins. 
7. While the polymer-metal mix is incubating, centrifuge the detection probe 
oligonucleotide from step 3 at 14000xg/4oC/30mins. 
8. Add 200µL of L-Buffer to a 3kDa filter. 
9. After incubation, add the metal loaded polymer from step 6 into the filter 
containing the L-Buffer. 
10. Centrifuge metal conjugated polymer at 12000xg/RT/25mins. 
11. Wash detection probe pellet from the centrifugation in step 7 twice in ice cold 
75% ethanol centrifuging at 14000xg/4oC/10mins. 
12. Add 300µL of C-Buffer to the 3kDa filter from step10 and centrifuge at 
12000xg/RT/30mins – leave at room temperature while completing detection 
probe purification. 
13. After final wash of detection probe in step 11, remove as much ethanol as 
possible (a brief centrifuge step (14000xg/4oC/30s) may help to pool residual 
ethanol for removal) and air dry the pellet (tube can be placed at 40oC on a 
heat block to decrease drying time). 
! CRITICAL STEP Failure to fully dry the pellet and remove all ethanol can affect 
downstream applications. Pellet is dry when it turns from opaque/white to bright 
white in colour. 
14. Assuming a yield of 80%, resuspend the dried pellet in C buffer (supplied in 
the metal labelling kit) to a concentration of 1nmol/25µL. For example, a 
starting quantity of 10nmoles would give an assumed yield of 8nmoles and 
would therefore be resuspended in 200µL of C buffer. 
15. Measure the reduced detection probe concentration from step 14 by 
absorption at 260nm on a nanodrop (use C buffer as a blank). 
16. Using the concentration from step 15, calculate the volume required for 2nmol 
of detection oligonucleotide (MW=6789g/mol) and transfer this to a fresh 
eppendorf. 
17. Transfer the entire metal loaded polymer from the 3kDa filter into the 
eppendorf containing the 2nmol oligonucleotide. 
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18. Increase the volume of the mixture to 100µL using C-Buffer and mix by 
pipetting. 
19. Incubate at room temperature for 2hrs. 
20. Add TCEP to a final concentration of 5mM, immediately mix by vortexing and 
incubate at room temperature for 30mins. 
21. Add 400µL ddH2O into a 30kDa filter. 
22. Transfer the metal-polymer-detection probe mixture into the 30kDa filter 
containing the ddH2O and centrifuge at 14000xg/RT/12mins. 
23. Discard flow through, add 500µL ddH2O to filter and centrifuge at 
14000xg/RT/12mins. 
24. Repeat step 23. 
25. Invert filter into a clean collection tube and centrifuge at 1000xg/RT/2min. 
26. Wash the filter with 250uL of ddH2O and elute into the same collection tube by 
inverting the filter and centrifuging at 1000xg/RT/2min. 
27. Measure the oligonucleotide concentration by nanodrop using ddH2O as a 
blank. 
28. Adjust the volume of ddH2O to give a final concentration of 1µM metal-
labelled detection probe (assuming 6789ng/mL = 1µM). 
29. Aliquot and store the metal-labelled detection probe at -20oC. 
! CRITICAL STEP Confirm efficient detection probe labelling by targeting a control 
gene which is known to have high copy number. For example, we have confirmed 
efficient detection probe labelling by using the cell line MAVER1 stained with PLAYR 
probe pairs containing the appropriate 3’ sequences all targeting the same loci on 
GAPDH mRNA (Figure 4C). 
? TROUBLESHOOTING 
 
- END OF BOX 1 -  
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Figure legends 
Figure 1. Schematic representation of the PLAYR assay 
(A) Schematic overview of PLAYR (Stages 1 - 8) for simultaneous staining of 
surface/intracellular proteins and mRNAs. The steps in the procedure are indicated 
for each stage. Initial staining of surface proteins is performed on ice in unfixed cells 
(stage 1). Bound antibodies are covalently cross-linked to the cells using the 
chemical agent BS3 (stage 2), and cells can then be fixed with paraformaldehyde 
and permeabilised using methanol (stage 3).  Once suspended in methanol, cells 
may be stored at -80oC for up to several months without loss of RNA integrity or 
surface antibody staining (Pause Point). Stages 4 to 8 illustrate the strategy for RNA 
detection using PLAYR. Intracellular antibody staining is performed during incubation 
of the PLAYR detection probes in stage 8. (B) Overview of the PLAYR probe design 
with different sequence components colour coded. Sequences with N vary 
depending upon their target (RNA-binding sequence) and the PLAYR system (insert-
binding sequence) used. (C) Diagram illustrates the interaction of different 
oligonucleotide sequences during the PLAYR assay. 5’ probe sequences bind to 
their target RNA (top). The insert and backbone oligonucleotides subsequently bind 
to the 3’ end of probe 1 and 2 (bottom). Colour coding of probe components is the 
same as in (B). 
Figure 2. Comparison of surface antigen staining in the PLAYR assay to a 
standard protocol for a panel of 27 antibodies  
Bivariate dot plots, coloured for event density, showing peripheral blood 
mononuclear cells simultaneously analysed for 27 surface proteins and measured by 
mass cytometry. Cells were either fixed first and then stained with antibody at room 
temperature (Standard staining protocol; top rows in each set of 9 panels) or 
antibody staining for use with PLAYR that includes BS3 crosslinking, fixation and 
permeabilisation steps (Staining for PLAYR; bottom rows in each set of 9 panels). 
For list of antibodies see Supplementary Table 1. 
Figure 3. Schematic of experimental design workflow for PLAYR 
Workflow showing: in silico experimental design (orange); acquisition of labelled 
detection probes either for mass (blue) or flow (green) cytometry; control 
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experiments for PLAYR RNA detection and antibody staining (pink); data collection 
and analysis of single-cell RNA expression in samples of interest (purple). 
Figure 4. Examples of control experiments for PLAYR 
(A) The B-cell line MAVER1, treated for up to 6hrs with 100nM PMA + 1µM 
ionomycin, was examined by PLAYR (mass cytometry) and qPCR for expression 
changes in 9 RNAs. Each dot represents the expression of the transcript at specific 
time points measured by qPCR (x-axis) and PLAYR (y-axis); Linear regression is 
represented by the blue line with grey shading indicating 95% confidence intervals.  
A.U. - Arbitrary Units. (B) Nine variably expressed mRNAs were examined 
(individually (rows 1-9) or multiplexed (row 10)) using the PLAYR assay, labelled 
with transcript specific detection probes (for mass cytometry) within primary leukemic 
cells from a CLL patient. (C) Validation of PLAYR system efficiency (including 
detection probe labelling) using 3 (top row) or 2 (bottom row) probe pairs targeting 
GAPDH mRNA in the MAVER1 B-cell line. 
Figure 5. Use of PLAYR for analysis of surface/internal protein and RNA 
expression in primary CLL cells 
(A) Quantification of three “housekeeping” mRNAs using PLAYR analysed by flow 
cytometry in primary peripheral blood mononuclear cells of CLL patients or the 
MEC1 cell line. Histograms are representative of 3 CLL samples and 3 MEC1 
biological replicates. (ATTO647 - Alexa-Fluor 647 equivalent from IDT technologies; 
For definition of Probes 1 and 2 see Fig. 1). (B) Flow cytometric quantification of 
ACTB mRNA (using PLAYR) in a mixed sample containing HUT78 T-cell line and the 
MAVER1 B-cell line. Singlet cells are gated using FSC and SSC (top 2 panels); The 
cell type was determined using CD5 and CD19 surface antigen expression (bottom 
left panel; purple gate - CD19-CD5++ HUT78; blue gate - CD19+CD5+ MAVER1); The 
shaded histograms in the bottom right panel show ACTB mRNA expression within 
the gated HUT78 and MAVER1 cells. Unshaded histograms depict ‘probe 2 only’ 
negative controls. (C) Gating strategy for mass cytometric detection of live singlet 
CLL cells and T-cells in human peripheral blood samples. (D) Mass cytometry data 
showing gating strategy to identify cells that have remained in the blood for an 
extended period of time, termed old quiescent (OQ; CD5dimCXCR4bright), and cells 
that have recently exited the tissue microenvironment, termed newly emerged (NE; 
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CD5brightCXCR4dim)18. (E) Percentages of CLL cells expressing the proliferative 
marker Ki67 within OQ and NE subpopulations of 18 CLL samples.  Results are 
comparable to previous findings that used flow cytometry18. Error bars represent one 
standard deviation from the mean. (F) Characterisation of intraclonal heterogeneity 
in expression of prognostic mRNAs19 (top row; CD83, JUND, TXNIP) and surface 
antigens (bottom row; CD21, CD22 and CD27) within cells resolved for CD5 and 
CXCR4 surface expression in a representative CLL sample. (G) viSNE analysis of 
the data in (F) based upon 9 CLL surface antigens (CD5, CD19, CD21, CD22, 
CD27, CXCR4, IgD and IgM). Top panel indicates event density coloured by 
temperature (high - red; low - blue) and the corresponding bottom panel highlights 
Ki67+ cells (red dots) within the viSNE contour plot. (H) viSNE plot from (G) with 
additional colour-coding for either mRNA (top row) or surface antigen expression 
(bottom row) to resolve expression for multiple parameters. 
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Table 1 – Oligonucleotide sequences for 27 PLAYR systems 
P, 5’-phosphorylated; Z, 5’-C6-thiol modification for mass cytometry or fluorophore modification for flow cytometry. 
 
 
System 3’ Probe1 3’ Probe2 Insert Detection Probe 
1 AAAAAAAAAACTCAGTCGTGACACTCTT AAAAAAAAAAGACGCTAATATCGTGACC P-ACGACTGAGTTTGGTCACGAT Z-ACGACTGAGTTTGGTCACGAT 
2 AAAAAAAAAATATCGTCCGGACACTCTT AAAAAAAAAAGACGCTAATCTTCGAGAC P-CGGACGATATTTGTCTCGAAG Z-CGGACGATATTTGTCTCGAAG 
3 AAAAAAAAAAGATTCCTCGGACACTCTT AAAAAAAAAAGACGCTAATCTGCCAATG P-CGAGGAATCTTTCATTGGCAG Z-CGAGGAATCTTTCATTGGCAG 
4 AAAAAAAAAACTACCTTGGGACACTCTT AAAAAAAAAAGACGCTAATCAGGCTACT P-CCAAGGTAGTTTAGTAGCCTG Z-CCAAGGTAGTTTAGTAGCCTG 
5 AAAAAAAAAACTCTTCGAGGACACTCTT AAAAAAAAAAGACGCTAATCACCAGTTG P-CTCGAAGAGTTTCAACTGGTG Z-CTCGAAGAGTTTCAACTGGTG 
6 AAAAAAAAAACTTAGCCTGGACACTCTT AAAAAAAAAAGACGCTAATCCAGACTGT P-CAGGCTAAGTTTACAGTCTGG Z-CAGGCTAAGTTTACAGTCTGG 
7 AAAAAAAAAACCGCTTATGGACACTCTT AAAAAAAAAAGACGCTAATCTACATGGC P-CATAAGCGGTTTGCCATGTAG Z-CATAAGCGGTTTGCCATGTAG 
8 AAAAAAAAAACTCGATCTGGACACTCTT AAAAAAAAAAGACGCTAATCAACCTGGT P-CAGATCGAGTTTACCAGGTTG Z-CAGATCGAGTTTACCAGGTTG 
9 AAAAAAAAAATACGTTCCGGACACTCTT AAAAAAAAAAGACGCTAATCATCCTGAG P-CGGAACGTATTTCTCAGGATG Z-CGGAACGTATTTCTCAGGATG 
10 AAAAAAAAAACTGCTCATGGACACTCTT AAAAAAAAAAGACGCTAATCGCAAGTCT P-CATGAGCAGTTTAGACTTGCG Z-CATGAGCAGTTTAGACTTGCG 
11 AAAAAAAAAATGACTCTCGGACACTCTT AAAAAAAAAAGACGCTAATCTCGGAATC P-CGAGAGTCATTTGATTCCGAG Z-CGAGAGTCATTTGATTCCGAG 
12 AAAAAAAAAACTGTCTACGGACACTCTT AAAAAAAAAAGACGCTAATCACAGTGTC P-CGTAGACAGTTTGACACTGTG Z-CGTAGACAGTTTGACACTGTG 
13 AAAAAAAAAATTCTCCAGGGACACTCTT AAAAAAAAAAGACGCTAATCTCAATCGG P-CCTGGAGAATTTCCGATTGAG Z-CCTGGAGAATTTCCGATTGAG 
14 AAAAAAAAAACACTTGTCGGACACTCTT AAAAAAAAAAGACGCTAATCAGATGCCT P-CGACAAGTGTTTAGGCATCTG Z-CGACAAGTGTTTAGGCATCTG 
15 AAAAAAAAAACTTCTGCAGGACACTCTT AAAAAAAAAAGACGCTAATCCAGGATCT P-CTGCAGAAGTTTAGATCCTGG Z-CTGCAGAAGTTTAGATCCTGG 
16 AAAAAAAAAATCTATCCGGGACACTCTT AAAAAAAAAAGACGCTAATCTGTAGACC P-CCGGATAGATTTGGTCTACAG Z-CCGGATAGATTTGGTCTACAG 
17 AAAAAAAAAACGCATCTTGGACACTCTT AAAAAAAAAAGACGCTAATCTGGCACAT P-CAAGATGCGTTTATGTGCCAG Z-CAAGATGCGTTTATGTGCCAG 
18 AAAAAAAAAATCTCACGTGGACACTCTT AAAAAAAAAAGACGCTAATCCTCGAATG P-CACGTGAGATTTCATTCGAGG Z-CACGTGAGATTTCATTCGAGG 
19 AAAAAAAAAATCGCTACTGGACACTCTT AAAAAAAAAAGACGCTAATCGCCATGAT P-CAGTAGCGATTTATCATGGCG Z-CAGTAGCGATTTATCATGGCG 
20 AAAAAAAAAATACGCTCTGGACACTCTT AAAAAAAAAAGACGCTAATCACACTTGG P-CAGAGCGTATTTCCAAGTGTG Z-CAGAGCGTATTTCCAAGTGTG 
21 AAAAAAAAAACGTCTTACGGACACTCTT AAAAAAAAAAGACGCTAATCATGCGACT P-CGTAAGACGTTTAGTCGCATG Z-CGTAAGACGTTTAGTCGCATG 
22 AAAAAAAAAACCATTCGTGGACACTCTT AAAAAAAAAAGACGCTAATCATCAGCGT P-CACGAATGGTTTACGCTGATG Z-CACGAATGGTTTACGCTGATG 
23 AAAAAAAAAACCTAGTTCGGACACTCTT AAAAAAAAAAGACGCTAATCTACCTAGG P-CGAACTAGGTTTCCTAGGTAG Z-CGAACTAGGTTTCCTAGGTAG 
24 AAAAAAAAAACTCCGATTGGACACTCTT AAAAAAAAAAGACGCTAATCAACGCGTT P-CAATCGGAGTTTAACGCGTTG Z-CAATCGGAGTTTAACGCGTTG 
25 AAAAAAAAAATTCGCACTGGACACTCTT AAAAAAAAAAGACGCTAATCAATTCCGG P-CAGTGCGAATTTCCGGAATTG Z-CAGTGCGAATTTCCGGAATTG 
26 AAAAAAAAAATCCTTCAGGGACACTCTT AAAAAAAAAAGACGCTAATCCGCTAAGT P-CCTGAAGGATTTACTTAGCGG Z-CCTGAAGGATTTACTTAGCGG 
27 AAAAAAAAAACGTTACTCGGACACTCTT AAAAAAAAAAGACGCTAATCTTAAGCGC P-CGAGTAACGTTTGCGCTTAAG Z-CGAGTAACGTTTGCGCTTAAG 
Universal Backbone: P-ATTAGCGTCCAGTGAATGCGAGTCCGTCTAGGAGAGTAGTACAGCAGCCGTCAAGAGTGTC 
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Step Problem Possible Cause Suggested Solution
32,36 and BOX1 
step30 
Little or no PLAYR signal RNA is low in cells of interest Use appropriate positive control cell line
Increase number of probe pairs 
Increase RCA time in step 28 
RNA degradation by release of 
internal RNases 
Confirm correct production of probe hybridisation buffer
Work fast after cell permeabolization with MeOH 
Keep cells cold at all times during wash steps 
Detection probe isn’t labelled 
efficiently 
Run titrated detection probe through the mass cytometer to confirm 
metal-labelling 
Insert or backbone 
oligonucleotides are not 5’-
phosphorylated 
Phosphorylate oligonucleotides with PNK 
Inefficient ligase or Phi29 enzyme 
activity  
Remove all wash buffer from the sample before addition of the 
enzyme reaction solution 
Confirm efficiency of the PLAYR system using highly expressed RNA 
transcript 
Use new batch of enzymes 
Weak antibody staining Antigen expression is low in 
target cells Confirm staining in positive control cells 
Low antibody concentrations Increase antibody concentrations
BS3 cross-linker has hydrolysed 
before contact with cells 
Use fresh BS3 cross-linker dissolved just before use 
Warm tube containing BS3 to RT prior to opening to avoid 
condensation  
Weak antibody cross-linking and 
PLAYR conditions are too harsh 
for the antibody clone 
Increase BS3 concentration 
Wash cells in icPBS to remove all non-cellular proteins from solution 
Reduce stringency of the PLAYR assay (see protocol optimisation)
High background PLAYR 
signals 
Non-specific probes Confirm specificity of the probe pairs in silico 
Test each probe pair individually 
Increase stringency of the PLAYR assay (temperature, post 
hybridisation wash, etc) 
Concentration of detection probe 
is too high 
Confirm using a negative control sample such as performing the assay 
when no ligase enzyme is added to the ligase reaction 
Titrate detection probe 
37 
 
Table 2 – Troubleshooting 
 
 
 
 
 
 
 
 
 
High background staining 
from antibody 
Antibody concentrations are too 
high Titrate antibody concentrations 
Not enough cells for 
analysis 
Not enough cells at the start of 
the assay 
Use a minimum of 3x106 primary leucocytes per sample and increase 
in necessary 
Loss of cells during assay Improve pipetting efficiency
During repeat washes, leave small quantities of supernatant to avoid 
the pellet 
Use swing rotors if not already doing so 
Figure1 
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